Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-599626 2HCL (AC480 2HCl) 是BMS-599626 衍生物。BMS-599626 是一种可口服且具有选择性的 HER1 和 HER2 双重抑制剂, IC50 分别为 20 和 30 nM。BMS-599626 抑制肿瘤细胞增殖,并有可能增加肿瘤对放疗的反应。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 673 | 现货 | ||
5 mg | ¥ 1,220 | 现货 | ||
10 mg | ¥ 2,430 | 现货 | ||
25 mg | ¥ 4,120 | 现货 | ||
50 mg | ¥ 5,880 | 现货 | ||
100 mg | ¥ 8,160 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,830 | 现货 |
产品描述 | BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative. BMS-599626 is an orally available and selective dual inhibitor of HER1 and HER2 with IC50s of 20 and 30 nM, respectively. BMS-599626 inhibits tumor cell proliferation and has the potential to increase tumor BMS-599626 inhibits tumor cell proliferation and has the potential to increase tumor response to radiotherapy. |
靶点活性 | HER2:30 nM, HER1:20 nM, HER4:190 nM |
体外活性 |
BMS-599626 is a potent HER inhibitor and has a higher inhibition ability than the other reported inhibitors. When tested with breast tumor cell lines (HCC202, HCC1942 and AU565) that highly expressed HER1 and HER2, BMS-599626 treatment inhibited cell proliferation, while having no effect on A2780 cells without HER1 or HER2 expression.[1] Treated OV202 cells with BMS-599626 significantly inhibited cell proliferation and enhanced cell apoptosis by inhibiting HER.[3] When tested with Sal2 cells expressing CD8-HER2 fusion protein, BMS-599626 treatment inhibited the receptor phosphorylation and MAPK phosphorylation with the IC50 value of 0.3 and 0.22 μM/L, respectively.[1] |
体内活性 | In mouse models with Sal2 tumor cells xenograft, oral administration of BMS-599626 inhibited Sal2 cells growth in a dose-dependent manner and significantly delayed tumor growth at the concentration of 60 mg/kg.[1] |
别名 | BMS 599626 dihydrochloride, BMS-599626 2HCL(714971-09-2 Free base), AC480 2HCl |
分子量 | 603.47 |
分子式 | C27H29Cl2FN8O3 |
CAS No. | 1781932-33-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (41.43 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.6571 mL | 8.2854 mL | 16.5708 mL | 41.4271 mL |
5 mM | 0.3314 mL | 1.6571 mL | 3.3142 mL | 8.2854 mL | |
10 mM | 0.1657 mL | 0.8285 mL | 1.6571 mL | 4.1427 mL | |
20 mM | 0.0829 mL | 0.4143 mL | 0.8285 mL | 2.0714 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BMS-599626 2HCL(714971-09-2 Free base) 1781932-33-9 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors HER BMS-599626 Dihydrochloride BMS 599626 dihydrochloride BMS 599626 Dihydrochloride AC-480 BMS599626 BMS599626 Dihydrochloride BMS 599626 BMS 599626 dihydrochloride (714971-09-2 free base) BMS-599626 AC480 2HCl AC 480 AC480 Inhibitor inhibitor inhibit